SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000903954-01-000014
Filing Date
2001-02-09
Accepted
2001-02-09 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G 0001.txt SC 13G 12103
  Complete submission text file 0000903954-01-000014.txt   14169
Mailing Address CREDIT SUISSE ASSET MANAGEMENT 153 EAST 53RD STREET NEW YORK NY 10022
Business Address 153 EAST 53RD STREET NEW YORK NY 10022 2128322626
CREDIT SUISSE ASSET MANAGEMENT /NY (Filed by) CIK: 0000903954 (see all company filings)

IRS No.: 133580284 | State of Incorp.: NY | Fiscal Year End: 1231

Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45671 | Film No.: 1529169
SIC: 2833 Medicinal Chemicals & Botanical Products